Congratulations to #ASGCT23 Outstanding Poster Presentation Awards Recipients

The top poster presentations from each of the three poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards. This year, 30 researchers received this honor. See who they are and read their abstracts below. 

If you're interested in this and related research, there's still time to register for the 26th Annual Meeting through June 19, 2023. All oral abstract sessions, select posters, and other educational programming are available on demand to registrants through June 23, 2023.

2023 Winners

Yanruide Li
Tumor-Localized Administration of α-GalCer to Recruit Invariant Natural Killer T Cells and Enhance Their Antitumor Activity Against Solid Tumors

Karthikeyan Ponnienselvan
Reducing the Inherent Auto-Inhibitory Interaction within the pegRNA Enhances Prime Editing Efficiency    Karthikeyan Ponnienselvan

Hector Ribeiro Benatti
A New Minimally Invasive Endovascular Approach to the Cerebello-Pontine Cistern Enables Improved AAV Biodistribution Compared to Cisterna Magna Injection

Sebastian Schellhorn
Targeting Oncolytic Adenoviruses to Cancer Cells Using a Designed Ankyrin Repeat Protein (DARPin) Lipocalin-2 (LCN2) Fusion Protein

David Liao
Optogenetic Therapy with MCO-010 for Vision Restoration in Patients with Severe Sight Loss Due to Retinitis Pigmentosa: The Phase 2b RESTORE Study

Jacob Wechsler
Injectable Stem Cell Therapy Enabled by Microgels to Alleviate Discogenic Low Back Pain

Elad Firnberg
Optimization of AAV-DARPin Fusions to Redirect Capsid Tropism

Beltran Borges
Prenatal Administration of AAV9-GFP in Fetal Lambs Results in Widespread Biodistribution and Transduction of Female, but Not Male, Germ Cells

Rafael Andres Badell-Grau
Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIC

Giselle Kaneda
iTenocytes on Microgrooved Scaffolds Promotes Achilles Tendon Regeneration

Malik Aydin
The Role of Natural Killer Cells During Adenovirus Infection: Implications for Adenovirus Based NK-cell Therapy

Carlos Theodore Huerta
E-selectin-Overexpressing Mesenchymal Stem Cell-Based Therapy Reverses Wound Healing Impairments in Ischemic Limbs

Simon Garaudé
Molecular Shielding of the Pan-Hematopoietic Marker CD45 May Enable a Universal Approach for Replacement of the Hematopoietic System

Wensen Jiang
A Cell Subtype-Mediated Mechanism Informs Cell Therapy Strategy for Discogenic Low Back Pain

Douglas Brown
Selective Ablation of Solid Tumors with Dysfunctional p53 Signaling Using a Suicide Gene Delivered via Fusogenix Proteolipid Vehicles

Miao Li
In Vivo Time-Course and Tissue-Wide Gene Profiling Reveals Distinct Signatures of CAR-T and CAR-iNKT Cell Responses to Solid Tumors

Jayanta Mondal
Neutrophils Conspire with CD8+ Exhausted T Cells to Promote Breast Cancer Lung Metastasis upon Loss of BRD7

Laura Pisani
RGX-111 Gene Therapy for the Treatment of Severe Mucopolysaccharidosis Type I (MPS I): Interim Analysis of Data from the First in Human Study

Dezhuang Ye
Focused Ultrasound-Mediated Intranasal Delivery of AAV to Targeted Brain Regions with Minimal Systemic Exposure

Maryam Hejazi
A Novel Fusogenix Proteolipid Vehicle-Based Platform for Efficient Delivery of Gene Therapy Products into the Eye

Domenica Martorana
Novel CGT Viral Vector Lysis Kit for AAV Enables a Standardized AAV Workflow from Cell Lysate to Absolute and Precise Quantification of Viral Titers

Katrin Schröer
Adenovirus Type 34 and HVR1-Deleted Adenovirus Type 5 Do Not Bind to PF4: Clearing the Path towards Vectors without Thrombosis Risk

Ugur Uslu
Combining CAR T Cell Therapy with Novel STING Agonist for Successful Treatment of Solid Tumors

Sara Feola
The Dirtier the Better: Viral Pre-Existing Immunity a Friend of Oncolytic Viruses Based Therapy

Anna Hartley
Generation and Persistent Genetic Modification of Virus- and Factor-Free Human iPSCs into Kidney Organoids Using S/MAR DNA Vectors

Kelcee Everette
Ex Vivo Prime Editing Corrects the Sickle Cell Allele in Hematopoietic Stem Cells and Corrects Disease Phenotypes in Mice

Jia Qi Cheng Zhang
Development of Miniaturized CRISPR Activation for a Single AAV Delivery Method for Muscular Dystrophy

Jennifer Waldo
Non-Evolved dCas9 Epigenetic Editors Targeting NGG PAM Sites Are Required for Knockdown of HTT

Kristen Ngai
Point Mutations on Omicron BA.5 Confer Vaccine and Antibody Evasion

Yanruide Li
Development of Allogeneic HSC-Engineered iNKT Cells for Off-the-Shelf Cancer Immunotherapy

Related Articles